FIELD: chemical-pharmaceutical industry and technology. SUBSTANCE: ondansetron hydrochloride dihydrate is prepared by mixing 3-[(dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carb- azole-4-one and 2-methylimidazole in medium of 55-65% aqueous dioxane in the presence of triethylamine at 33-42 C followed by mixture cooling and water addition. Obtained precipitate is filtered off, washed with water and suspended in 70-80% aqueous acetone followed by addition of hydrochloric acid and settling the reaction mixture for 0.5-1.5 h. Then acetone is added, precipitate is separated and dried at the room temperature. Obtained substance has crystals (size is less 90 mcm) being 95% of crystals have the size less 60 mcm. EFFECT: stable and pure product making. 8 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING ANTIEMETIC MEDICATION | 2006 |
|
RU2439057C2 |
DERIVATIVES OF CARBAZOLONE AND METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2119914C1 |
MEDICINAL AGENT | 2002 |
|
RU2229882C2 |
METHOD OF OBTAINING IMIDAZOLE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS | 0 |
|
SU1528319A3 |
METHOD FOR PREPARING IMIDAZOLYL COMPOUNDS | 2003 |
|
RU2314296C2 |
METHOD FOR PREPARING 1,2,3,9-TETRAHYDRO-9-METHYL-3-[(2-METHYL-1H-IMIDAZOLE-1-YL)METHYL]-4H-CARBAZOLE-4-ONE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 2001 |
|
RU2207340C2 |
PROCESS FOR PREPARING 1,2,3,9-TETRAHYDRO -9-METHYL -3-[(2-METHYL-1H-IMIDAZOL -1-YL)METHYL]-4H- CARBAZOL-4-ONE OR SALTS THEREOF OR HYDRATES THEREOF, AND INTERMEDIATE PRODUCTS OF SYNTHESIS THEREOF | 1993 |
|
RU2041876C1 |
PHARMACEUTICAL COMPOSITION FOR REDUCTION OF PRIMARY RADIATION RESPONSE AND EARLY TRANSIENT INCAPABILITY | 2012 |
|
RU2509557C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND METHACINE | 2001 |
|
RU2185825C1 |
METHOD FOR SYNTHESIS OF CARBAZOLE DERIVATIVES OR THEIRS PHYSIOLOGICALLY ACCEPTABLE SALTS | 0 |
|
SU1731047A3 |
Authors
Dates
2001-02-10—Published
2000-07-14—Filed